Member Info for MrMagorium

I've bought a small amount, because as you guys all highlight. 250k for a listing is a drop in the ocean. Let's see what happens. GLA!

IMO, they appear to have had a strong few years, made some decent cash, but now it looks like the products they are selling no longer hold the same value to consumers as they did during peak Covid.

LFT are getting cheaper. As a small example I can get a pack or LF tests at a local discount store. That suggests to me there is a further risk of reduced profit margins, as well as lower revenues for these products, as market share potentially is reduced.

Big question for me now, is how will the BOD stem the decline in revenue from Covid tests, because that ship looks to have sailed at the current time.

Ever a pessimist, but I can see revenue potentially dropping off a cliff, without the right strategic action to substitute the COVID test revenues.

GLA. AIMHO. DYOR etc.

Itisagame, do you think there is lack of trust in the 500k claimed as being distributable to shareholders? I believe that was communicated on the basis of the company being delisted, which wasn't successful. So more costs come in to play.

It's currently trading at a circa 50% discount to 500k, which may indicate the market has doubt in the numbers the BOD have highlighted.

Agreed, there could be value in the listing if somewhere were to act quickly, but I have a horrible feeling the 500k could be being drained now.

Hopefully someone comes along to snap it up before it runs out of cash. Cash shells appear to have performed diabolically over the last 12 months.

GLA

I checked the last annual report, chair is 70k and CFO is 180k basics per annum according to that, so my numbers are based on published documents. This is such a low market cap now, it piqued my interest.

Poor, are the remaining NED and CFO on the board taking their salaries from this business?

That's circa 250k worth of basic remuneration per annum which could come out of the coffers.

Big saving for the new business, if it is.

Do you think the reduced profit margin signals concern? They seem to indicate a switching Product mix from PCR to Lateral flows as being the driver. In general, it looks like the majority of their revenue comes from Covid tests. In the event covid test demand start to fall, that could mean their revenues follow the same pattern.

I do think the other at home health test checks they offer, could have significant potential, but they need to start drumming up demand, whilst softening the blow from the reduction in Covid Test Revenue, it would seem.

Decent cash balance, so hopefully can use it to drive the business forward.

The significant lift off is based upon what logic? As I understand expected less than 500k proceeds to shareholders, so the current valuation seems in the range around where it should be trading. What price you putting on this?